Locations

Showing 1141 Locations
Sort by:
  • Netherlands

    Metamorphogenesis • Tripsitters • Trip Therapie • Het Wonder Van Bestaan • Binnenreizen • A Whole New High • Inward Bound • New Moon Psychedelic Retreats • Kiyumi • Plant Medicine Miracles • Guided Tripping • Essence Institute • Truffle Healing • Earth Resonance • Cyber-Shrooms • ProviThor • Wholecelium

  • Neuss, North Rhine-Westphalia, Germany

    Ketamine Challenge Study With JNJ-40411813

  • Nevada, USA

    Mike O'Callaghan Military Hospital

  • New Brunswick, New Jersey, USA

    Johnson & Johnson

  • New Cairo, Egypt

    Intranasal Ketamine and Midazolam Mixture for Procedural Sedation in Children With Mental Disabilities:

  • New Canaan, Connecticut, USA

    Innovating Capital

    George Lovas

  • New Delhi, India

    Ketamine for Pain Relief in Bariatric Surgery • A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy • A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

  • New Haven, Connecticut, USA

    Yale University • Alexion Pharmaceuticals

    A Study of Psilocybin for Major Depressive Disorder (MDD) • Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. • The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. • Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy • Ketamine Infusion for Obsessive-Compulsive Disorder • Ketamine Infusion for Social Anxiety Disorder • The Sustained Effects of Ketamine • Ketamine in Borderline Personality Disorder • PET Imaging of mGLuR5 With Drug Challenge • Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine • Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy • Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response • Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects • A Study of Ketamine in Patients With Treatment-resistant Depression • ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) • Ketamine Infusion for Adolescent Depression and Anxiety • Ketamine for Low Mood States in the ER • The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects • Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling • A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Biomarker Assessment of Glutamatergic Target Engagement • Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects • Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression • The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers • Compare the Effect of Propofol vs. "Ketofol" on Hemodynamic Stability During Induction of General Anesthesia • Characterizing Clinical and Pharmacological Neuroimaging Biomarkers • Imaging SV2A in Mood Disorders • Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

  • New Hyde Park, New York, USA

    Northwell Health

    Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

  • New Orleans, Louisiana, USA

    The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD

  • New South Wales, Australia

    Chief Operating Officer

    Ketamine Trial for the Treatment of Depression • Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT) • A Study of Ketamine as an Antidepressant • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

  • New York City, New York, USA

    Maimonides Medical Center

  • New York, New York, USA

    Fraqtal • Gilgamesh Pharmaceutical • Mindbloom • Optosom • Pfizer • Seelos • ONE Integration • Perception Neuroscience • The Center for Optimal Living • Horizons • Evolver • Pharmacology & Therapeutics • Ketamind • Noah Potter Law • Vicente Sederberg • KCSA • Mattio Communications • Four Sigmatic • NYU Langone Health • Columbia University • Icahn School of Medicine at Mount Sinai • Weill Medical College of Cornell University • Gabrielle's Angel Foundation • American Foundation for Suicide Prevention • Neurogene Inc. • The Ketamine Research Foundation • Brain & Behavior Research Foundation • Bronx Veterans Medical Research Foundation, Inc • New York City Health and Hospitals Corporation • New York State Psychiatric Institute • New York Presbyterian Hospital • The Brooklyn Hospital Center • Hospital for Special Surgery, New York • Target Health Inc. • Roivant Sciences, Inc. • National Multiple Sclerosis Society • THRiVE • Memorial Sloan Kettering Cancer Center • Forest Laboratories • Zuber Lawler • Heally • AIkido Pharma • Frequency

    Tabula Rasa Ventures • 14W • Able Partners • Innovating Capital • Michael Novogratz • New Enterprise Associates (NEA) • Presight Capital • Psilos Group • Subversive Capital • Republic Labs • Energia • General Catalyst • Decheng Capital • JLS Fund • Falcon Edge Capital • Pura Vida Investments • Highline Capital • WPSS • Negev Capital • Mont Alo Capital

    Marik Hazan • Alex Zubillaga • Ryan Ackell • Lisa Blau • Alison Ryu • Amanda Eilian • Eric Chen • Andrew Amarosa • Michael Novogratz • Crystal Huang • Tony Florence • Tina He • Fabian Hansen • Patrick Farrell • Joseph Riley • David Eichler • Guy Levy • Steve Musumeci • Greg Dryer • Copter Ruangrojanin • Jay Campbell • Peter Molloy • Peter McDonough • Everett Ware • Peter Di Iorio • Aly Beynon

    Chief Financial Officer (m/f/d) • Finance Manager (m/f/d) • Nurse Practitioner • Psychotherapist • FP&A Manager | R&D Finance • Group Controller • Legal Counsel (Corporate) • VP FP&A • VP Human Resources/People • Psychiatric Mental Health Nurse Practitioner • Executive Assistant • DevOps Engineer • Public Relations Manager • Unsolicited application • Director of IT and Enterprise Applications • Software Engineering and IT Project Manager • Data Scientist • Machine Learning Scientist • Training Programme Lead • Legal compliance analyst / paralegal • Project Manager, Drug Discovery Center, 2 year contract position, with potential for extension • Licensed Psychotherapist

    A Study of Psilocybin for Major Depressive Disorder (MDD) • The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals • The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Psilocybin Cancer Anxiety Study • A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence • Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • The Role of HNKs in the Antidepressant Effect of Ketamine • Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder • Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) • Ketamine in the Treatment of Depression • Low-Dose Ketamine in Children With ADNP Syndrome • Ketamine in the Treatment of Suicidal Depression • Ketamine for Suicidality in Bipolar Depression • Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD • Ketamine and Nitroprusside for Depression • A Comparison of Intra-op Ketamine vs Placebo in Patients Having Spinal Fusion • Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus • Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP) • Continuation Ketamine in Major Depression • Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome • Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects • Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients • Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD) • Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression • A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion • Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) • Intranasal Ketamine in Treatment-Resistant Depression • Ketamine For Suicidal Ideation • A Study of Ketamine in Patients With Treatment-resistant Depression • Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD) • Pharmacokinetic Alterations During ECMO • Optimization of IV Ketamine for Treatment Resistant Depression • ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) • Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects • Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy • Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy • Ketamine Plus Lithium in Treatment-Resistant Depression • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Research Study for Major Depressive Disorder: Investigation of Glutamate Medications • Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery • Biomarker Assessment of Glutamatergic Target Engagement • Treatment Study of Bipolar Depression • The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence • NMDA Antagonists in Bipolar Depression • Glutamatergic Modulation of Cocaine-related Deficits • Glutamatergic Modulation of Disordered Alcohol Use • Facilitating the Behavioral Treatment of Cannabis Use Disorder • Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder • The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking • Facilitating Rapid Naltrexone Initiation • Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence • Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders • Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery. • MRI Studies of Emotion in Depression • Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy • Feasibility of Electro Auricular Acupuncture for Analgesia After ACL Surgery: The Feasibility of Patient Blinding and Effects on Early Postoperative Pain • Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • Ketamine for Older Adults Pilot • Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

  • New York, USA

    Fluence

    UI/UX Designer • Full Stack Software Engineer • VP Project Direction

  • Newark, New Jersey, USA

    Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome

  • Newark, Ohio, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Newcastle upon Tyne, England, United Kingdom

    Newcastle University

    The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Newton, Massachusetts, USA

    Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

  • Nice, Provence-Alpes-Côte d'Azur, France

    Centre Hospitalier Universitaire de Nice • Fondation Lenval

    Intranasal Ketamine and Fracture Reduction in Pediatric Emergencies (KETAPED) • Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Nijmegen, Gelderland, Netherlands

    Canisius-Wilhelmina Hospital • University Medical Center Nijmegen

    Prevention of Phantom Limb Pain After Transtibial Amputation

  • Nîmes, Occitanie, France

    Centre Hospitalier Universitaire de Nīmes

    Effects of Ketamine in the Acute Phase of Suicidal Ideation • Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room • The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

  • Nokomis, Florida, USA

    Mycology Now

  • Nordbyhagen, Norway

    University Hospital, Akershus

  • Nordland, Norway

    Nordlandssykehuset HF

  • Norfolk, Virginia, USA

    Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

  • Normal, Illinois, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Norman, Oklahoma, USA

    University of Oklahoma

  • North Dartmouth, Massachusetts, USA

    Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

  • North Haven, Connecticut, USA

    Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

  • North Holland, Netherlands

    Prevention of Phantom Limb Pain After Transtibial Amputation • Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study

  • North Hollywood, California, USA

    Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD

  • North Vancouver, British Columbia, Canada

    Lions Gate Hospital • North Shore Health Research Foundation

    Intra-nasal Ketamine for Analgesia in the Emergency Department • Ketofol vs Propofol for Emergency Department Procedural Sedation and Analgesia

  • North York, Ontario, Canada

    Allevio Pain Management Clinic • The Physicians' Services Incorporated Foundation

  • Northridge, California, USA

    Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Nottingham, England, United Kingdom

    Worldwide Clinical Trials • Quotient Clinical

    A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

  • Novato, California, USA

    BioMarin Pharmaceutical

  • Nunavut, Canada

    Marketing Coordinator

  • Oak Lawn, Illinois, USA

    The Effect of Etomidate on Patient Outcomes After Single Bolus Doses

  • Oakland, California, USA

    OLP Therapeutics • Sage Institute • Mimosa Therapeutics • Alameda Health System • UCSF Benioff Children's Hospital Oakland • Decriminalize Nature

    Adherence and Supervision Coordinator • Document Control Specialist - Remote Position

    Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department • Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • US-guided SAPB for Rib Fractures in the ED

  • Okinawa-ken, Japan

    Alien Insect

  • Oklahoma City, Oklahoma, USA

    Ketamine for Post-operative Analgesia in Hemorrhoidectomy • Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

  • Omaha, Nebraska, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer • Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Ontario, Canada

    Empower Clinics, Inc. • Adventures Through The Mind

    VP Partnerships & Business Development

  • Orange, California, USA

    A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

  • Orangeburg, New York, USA

    Nathan Kline Institute for Psychiatric Research

    Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Sodium Oxybate in Schizophrenia With Insomnia

  • Oregon, Ohio, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Orem, Utah, USA

    Medical Assistant - Salt Lake City and Orem Positions Open